Jessica M. Rusert, Ph.D.
Affiliations: | 2012 | Biology | University of California, San Diego, La Jolla, CA |
Area:
axonal transportGoogle:
"Jessica Rusert"Mean distance: 17.38 (cluster 32)
Parents
Sign in to add mentor| Lawrence SB Goldstein | grad student | 2012 | UCSD | |
| (Modeling Hematopoietic Cell Development and Chronic Myeloid Leukemia with Human Embryonic Stem Cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Borgenvik A, Holmberg KO, Bolin S, et al. (2022) Dormant SOX9-positive cells facilitate MYC-driven recurrence of medulloblastoma. Cancer Research |
| Bolin S, Savov V, Borgenvik A, et al. (2017) TMOD-31. RARE SOX9+ CELLS BEHIND MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE Neuro-Oncology. 19: vi260-vi261 |
| Goff DJ, Court Recart A, Sadarangani A, et al. (2013) A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. Cell Stem Cell. 12: 316-28 |
| Jiang Q, Crews LA, Barrett CL, et al. (2013) ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 110: 1041-6 |
| Jiang Q, Crews LA, Barrett CL, et al. (2013) Abstract 247: ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Cancer Research. 73: 247-247 |
| Jiang Q, Crews-Robertson L, Barrett CL, et al. (2012) The RNA Editase ADAR1 Promotes Malignant Progenitor Reprogramming in Chronic Myeloid Leukemia. Blood. 120: 2772-2772 |
| Goff D, Smith KM, Shih AY, et al. (2011) BCL2 Splice Isoform Switching Promotes Leukemia Stem Cell Survival and Sensitivity to a Novel Pan BCL2 Inhibitor Blood. 118: 2735-2735 |